ViaNautis has developed PolyNaut®, a versatile nano-engineered polymer technology designed for targeted intracellular delivery
ViaNautis has raised €23M across 1 funding round from 8 investors, most recently a Series A round in Nov 2023. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-11-13 | Series A | €23M |
| 4BIO Capital,BGF,Cystic Fibrosis Foundation,Eli lilly and company,Meltwind,o2h Ventures+2 more |
| View deal → |
